CRISPR THERAPEUTICS AG

Ticker: CRSP CUSIP: H17182108 Class: NAMEN AKT

MARSHALL WACE, LLP's Holding History (CIK: 0001318757)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 393,295 Value ($000) $13,384 Avg Close $42.39 Range $32.96 - $55.88
Q2 2024
Shares 186,591 Value ($000) $10,078 Avg Close $57.84 Range $51.02 - $68.39
Q4 2023
Shares 3,200 Value ($000) $200 Avg Close $55.02 Range $37.55 - $76.97
Q3 2023
Shares 135,947 Value ($000) $6,171 Avg Close $51.65 Range $44.53 - $59.67
Q2 2023
Shares 457,008 Value ($000) $25,656 Avg Close $56.74 Range $43.10 - $72.00
Q3 2022
Shares 10,893 Value ($000) $712 Avg Close $72.47 Range $60.41 - $86.95
Q3 2021
Shares 255,727 Value ($000) $28,624 Avg Close $125.59 Range $109.63 - $163.00
Q1 2020
Shares 1,917 Value ($000) $81 Avg Close $51.63 Range $32.30 - $64.19
Q4 2019
Shares 2,374 Value ($000) $145 Avg Close $54.60 Range $35.46 - $74.00
Q1 2018
Shares 4,627 Value ($000) $212 Avg Close $41.27 Range $23.01 - $61.24